Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Myelodysplastic Syndromes 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Leukemia 1Congenital Abnormalities 1Anemia, Refractory, with Excess of Blasts 1

Interventions

Radiotherapy 3Methotrexate 3Cytarabine 3Cyclosporine 3Peripheral Blood Stem Cell Transplantation 2Daunorubicin 2Cyclophosphamide 2Busulfan 2zosuquidar trihydrochloride 1sargramostim 1merphos 1hydrocortisone hemisuccinate 1Whole-Body Irradiation 1Thioguanine 1Stem Cell Transplantation 1Photopheresis 1Pentostatin 1Mycophenolic Acid 1Methoxsalen 1Idarubicin 1Hydrocortisone 1Granulocyte Colony-Stimulating Factor 1Gemtuzumab 1Filgrastim 1Cyclosporins 1Colony-Stimulating Factors 1Asparaginase 1Antilymphocyte Serum 1Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Anemia, Refractory, with Excess of Blasts × zosuquidar trihydrochloride × Clear all
NCT00046930 2023-07-05

Daunorubicin & Cytarabine +/- Zosuquidar inTreating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or Refractory Anemia

Eastern Cooperative Oncology Group

Phase 3 Completed
449 enrolled 9 charts
Classical hematologyMyeloidOther hematologic neoplasm

Congenital Abnormalities, Anemia, Refractory, with Excess of Blasts, Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡